Distal Femoral Musculoskeletal Tumors
Conditions
Keywords
Megaprosthesis, Musculoskeletal tumor, Distal femur, Lower limb, Functional mobility, Quality of life, Case-Control Study, Inertial Measurement Unit
Brief summary
This study aims to evaluate the functional outcomes of patients with distal femur tumor prostheses in comparison to a matched control group.
Detailed description
The aim of this case-control study will be to compare functional outcomes-including results from the TUG and 6MWT, knee flexor and extensor muscle strength, sagittal knee range of motion-and health-related quality of life between patients with distal femoral megaprostheses and healthy controls. By employing both traditional assessments and IMU technology, the investigators will provide a comprehensive evaluation of functional recovery in this population, thereby informing clinical practice and rehabilitation strategies. Two functional tests that will be conducted are the Time Up and Go Test and the 6-Minute Walk Test. These tests will be administered using a non-invasive Inertial Measurement Unit (IMU), specifically the BTS G-sensor inertial sensor (BTS Bioengineering, Garbagnate Milanese, Italy), positioned at the S1 level to collect spatiotemporal gait data. These data will then be analyzed in comparison to values obtained from healthy participants. The assessment will include anamnesis and a complete clinical examination of tumor patients with distal femur megaprostheses undergoing surgery at Hospital la Fe in Valencia, focusing on knee joint mobility and muscle group strength. Subjective function will be evaluated using questionnaires such as the SF-36 for both cases and controls and the MSTS (Musculoskeletal Tumor Society Score) for cases.
Interventions
None listed
Sponsors
Cardenal Herrera University
Study design
Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
16 Years to 99 Years
Healthy volunteers
Yes
Inclusion criteria
(cases group): * Megaprosthesis of unilateral distal femur * Tumor cause * Ambulation capacity
Exclusion criteria
(cases group): * Neurological alterations prior to the inervention than affect the lower limbs or general movement * Patient incapable of ambulation due to progression of his/her pathology * Patient with palliative treatment for advanced tumor diseas * More than one ipsilateral or contralateral prosthesis * Infection, traumatic or sequel to revision surgery cause
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| SF-36 questionnaire | 3 months | This instrument assesses health-related quality of life and comprises 36 items, organized into eight subscales: physical functioning (10 items), physical role functioning (4 items), bodily pain (2 items), general health perceptions (5 items), vitality (4 items), social functioning (2 items), emotional role functioning (3 items), and mental health (5 items). Each subscale is scored on a scale from 0 to 100, with higher scores indicating better health status in that domain. In addition to individual subscale scores, two aggregate summary scores are calculated: the Physical Component Summary (PCS) and the Mental Component Summary (MCS). These summary scores are norm-based, with a mean of 50 and a standard deviation of 10, allowing comparison to population averages. Scores above 50 represent better-than-average health, while scores below 50 indicate lower-than-average health-related quality of life. |
| Timed Up and Go Test | 3 months | Participants are seated in a chair with their backs against the backrest and their hands resting on their thighs. Upon the verbal command GO, they are instructed to stand, walk down a 3-meter pathway, turn around, and return to a seated position as quickly and safely as possible. The recorded parameters include total TUG time (s), rotation speed during the middle and final turns (°/s), and vertical acceleration during the sit-to-stand and stand-to-sit transitions (m/s²) |
| 6 -Minute Walk Test | 3 months | This test is conducted in a continuous 30-meter corridor, where participants are instructed to walk for 6 minutes at their own preferred pace. The primary parameter measured is total walking distance (m) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Sagittal range of movement of the knee measured with a goniometer | 3 months | Sagittal range of movement of pathologic knee and healthy knee in controls.Full knee extension is considered 0º. The full range of knee mobility determined by the sum of the degrees of flexion plus the degrees of extension. |
| Muscular strength | 3 months | We measure muscle strength in the quadriceps and hamstrings of the pathological leg in the cases and one of the legs in the controls. For this we use the Medical Research Council Scale. On this scale, contraction is assessed from 0-5. Grade 5: Normal Grade 4: Movement against gravity and resistance Grade 3: Movement against gravity over (almost) the full range Grade 2: Movement of the limb but not against gravity Grade 1: Visible contraction without movement of the limb Grade 0: No visible contraction |
| MSTS Score | 3 months | Musculoskeletal Tumour Society (MSTS) Score evaluates patients' subjective functional capabilities. This assessment comprises six subscales: pain, function, emotional acceptance, use of assistive devices for ambulation, walking ability, and gait. Each subscale is rated on a scale from 0 to 5 points, with 5 indicating the most favorable outcome. Total scores are categorized as follows: poor (\<15%), fair (15-17%), moderate (18-20%), good (21-22%), and excellent (23-30%). Higher total scores reflect better functional performance |
Countries
Spain
Outcome results
None listed